Search

Your search keyword '"Viral Matrix Proteins chemistry"' showing total 891 results

Search Constraints

Start Over You searched for: Descriptor "Viral Matrix Proteins chemistry" Remove constraint Descriptor: "Viral Matrix Proteins chemistry" Topic viral matrix proteins Remove constraint Topic: viral matrix proteins
891 results on '"Viral Matrix Proteins chemistry"'

Search Results

1. Assembly and activation of EBV latent membrane protein 1.

2. Insights into the specific feature of the electrostatic recognition binding mechanism between BM2 and BM1: a molecular dynamics simulation study.

3. Conformations of influenza A M2 protein in DOPC/DOPS and E. coli native lipids and proteins.

4. Membrane curvature sensing and symmetry breaking of the M2 proton channel from Influenza A.

5. Structure and dynamics of the proton-selective histidine and the gating tryptophan in an inward rectifying hybrid influenza B and A virus M2 proton channel.

6. Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers.

7. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.

8. High-throughput virtual screening of Streptomyces spp. metabolites as antiviral inhibitors against the Nipah virus matrix protein.

9. The impact of transmembrane peptides on lipid bilayer structure and mechanics: A study of the transmembrane domain of the influenza A virus M2 protein.

10. The C-terminus of Sudan ebolavirus VP40 contains a functionally important CX n C motif, a target for redox modifications.

11. Inside and outside of virus-like particles HBc and HBc/4M2e: A comprehensive study of the structure.

12. Molecular origins of asymmetric proton conduction in the influenza M2 channel.

13. A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages.

14. PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.

15. A single-shot vaccine approach for the universal influenza A vaccine candidate M2e.

16. Emulating Membrane Protein Environments─How Much Lipid Is Required for a Native Structure: Influenza S31N M2.

17. Helical ordering of envelope-associated proteins and glycoproteins in respiratory syncytial virus.

18. Ebola virus protein VP40 binding to Sec24c for transport to the plasma membrane.

19. Ubiquitination on Lysine 247 of Newcastle Disease Virus Matrix Protein Enhances Viral Replication and Virulence by Driving Nuclear-Cytoplasmic Trafficking.

20. Multiscale Simulation of an Influenza A M2 Channel Mutant Reveals Key Features of Its Markedly Different Proton Transport Behavior.

21. Elucidation of SARS-Cov-2 Budding Mechanisms through Molecular Dynamics Simulations of M and E Protein Complexes.

22. Respiratory Syncytial Virus Matrix Protein-Chromatin Association Is Key to Transcriptional Inhibition in Infected Cells.

23. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.

24. New structural insights into the multifunctional influenza A matrix protein 1.

25. Key Amino Acids of M1-41 and M2-27 Determine Growth and Pathogenicity of Chimeric H17 Bat Influenza Virus in Cells and in Mice.

26. Amino- and carboxyl-terminal ends of the bovine parainfluenza virus type 3 matrix protein are important for virion and virus-like particle release.

27. Subtype Differences in the Interaction of HIV-1 Matrix with Calmodulin: Implications for Biological Functions.

28. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.

29. Water-Triggered, Irreversible Conformational Change of SARS-CoV-2 Main Protease on Passing from the Solid State to Aqueous Solution.

30. Structure of Usutu virus SAAR-1776 displays fusion loop asymmetry.

31. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.

32. Challenging the Existing Model of the Hexameric HIV-1 Gag Lattice and MA Shell Superstructure: Implications for Viral Entry.

33. Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface.

34. Targeting Viral Surface Proteins through Structure-Based Design.

35. Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations.

36. De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation.

37. Dynamic Cooperativity of Ligand-Residue Interactions Evaluated with the Fragment Molecular Orbital Method.

38. Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses.

39. Dual-axis Volta phase plate cryo-electron tomography of Ebola virus-like particles reveals actin-VP40 interactions.

40. IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein.

41. Synthesis, antioxidant, antimicrobial and antiviral docking studies of ethyl 2-(2-(arylidene)hydrazinyl)thiazole-4-carboxylates.

42. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.

43. Reasonable permutation of M2e enhances the effect of universal influenza nanovaccine.

44. Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs.

45. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.

46. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.

47. Rabies virus matrix protein targets host actin cytoskeleton: a protein-protein interaction analysis.

48. MEDT study of the 1,3-DC reaction of diazomethane with Psilostachyin and investigation about the interactions of some pyrazoline derivatives with protease (M pro ) of nCoV-2.

49. The Structural Features of Henipavirus Matrix Protein Driving Intracellular Trafficking.

50. Conformational triggers associated with influenza matrix protein 1 polymerization.

Catalog

Books, media, physical & digital resources